Decoy Therapeutics DCOY
NASDAQ DCOY
$1.08 -0.06 (-5.29%)
As of: Oct 21, 2026 · 3:55 PM EDT

Decoy Therapeutics (DCOY) Change in Receivables (2016 - 2020)

Updated

Decoy Therapeutics' Change in Receivables came in at -$1.83 million for Q3 2020, compared with -$690.00 a year earlier.

Analysis

Decoy Therapeutics (DCOY) Change in Receivables (2016 - 2020) Analysis & Trends

For FY2019, Decoy Therapeutics' Change in Receivables was -$690.00.

  • Going back by year, Change in Receivables was -$1,796 in FY2017 and $12,181 in FY2016.
  • The Q3 2020 figure represents the lowest quarterly Change in Receivables in data going back to Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Decoy Therapeutics 571,865.63 -31.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -1.83 Mn
Jun 30, 2020 1.24 Mn
Mar 31, 2020 591,129.00
Sep 30, 2019 -690.00
Sep 30, 2018 -184.00
Jun 30, 2018 4,698.00
Mar 31, 2018 -4,514.00
Dec 31, 2017 -24,749.00
Sep 30, 2017 399.00
Jun 30, 2017 15,673.00
Mar 31, 2017 6,881.00
Dec 31, 2016 -9,606.00
Sep 30, 2016 10,192.00
Jun 30, 2016 11,595.00
API Access

Decoy Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=DCOY&period=max&api_key=YOUR_API_KEY